Approval Year
| Substance Class |
Protein
Created
by
admin
on
Edited
Tue Apr 01 20:23:34 GMT 2025
by
admin
on
Tue Apr 01 20:23:34 GMT 2025
|
| Protein Type | MONOCLONAL ANTIBODY |
| Protein Sub Type | IGG4 |
| Sequence Origin | HUMANIZED MOUSE |
| Sequence Type | COMPLETE |
| Record UNII |
Z7HVY03PHP
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Related Record | Type |
|---|
| Name | Type | Language | ||
|---|---|---|---|---|
|
Official Name | English | ||
|
Preferred Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
FDA ORPHAN DRUG |
577817
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
||
|
FDA ORPHAN DRUG |
584617
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
Z7HVY03PHP
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
PRIMARY | |||
|
Z7HVY03PHP
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
PRIMARY | |||
|
C170182
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
PRIMARY | |||
|
DE-114
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
PRIMARY | |||
|
1884201-71-1
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
PRIMARY | |||
|
300000025307
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
PRIMARY | |||
|
10657
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
PRIMARY | |||
|
DB14910
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
PRIMARY | |||
|
Mirikizumab
Created by
admin on Tue Apr 01 20:23:34 GMT 2025 , Edited by admin on Tue Apr 01 20:23:34 GMT 2025
|
PRIMARY |
| From | To |
|---|---|
| 1_22 | 1_96 |
| 1_129 | 3_214 |
| 1_142 | 1_198 |
| 1_221 | 2_221 |
| 1_224 | 2_224 |
| 1_256 | 1_316 |
| 1_362 | 1_420 |
| 2_22 | 2_96 |
| 2_129 | 4_214 |
| 2_142 | 2_198 |
| 2_256 | 2_316 |
| 2_362 | 2_420 |
| 3_23 | 3_88 |
| 3_134 | 3_194 |
| 4_23 | 4_88 |
| 4_134 | 4_194 |
| Glycosylation Type | MAMMALIAN |
| Glycosylation Link Type | Site |
|---|---|
| N | 1_292 |
| N | 2_292 |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
TARGET -> INHIBITOR | |||
|
|
SUB_CONCEPT->SUBSTANCE |
|
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |
Structural Modifications
| Modification Type | Location Site | Location Type | Residue Modified | Extent | Fragment Name | Fragment Approval |
|---|---|---|---|---|---|---|
| AMINO_ACID_SUBSTITUTION | [1_1] [2_1] | N-TERMINUS | PIDOLIC ACID | SZB83O1W42 |
| Name | Property Type | Amount | Referenced Substance | Defining | Parameters | References |
|---|---|---|---|---|---|---|
| Molecular Formula | CHEMICAL |
|
||||
| MOL_WEIGHT:NUMBER(CALCULATED) | CHEMICAL |
|